- Review
Hormone Receptor Signaling and Breast Cancer Resistance to Anti-Tumor Immunity
- Alexandra Moisand,
- Mathilde Madéry,
- Thomas Boyer,
- Charlotte Domblides,
- Céline Blaye and
- Nicolas Larmonier
Breast cancers regroup many heterogeneous diseases unevenly responding to currently available therapies. Approximately 70–80% of breast cancers express hormone (estrogen or progesterone) receptors. Patients with these hormone-dependent breast m...